Specker Jona, Focquaert Farah, Raus Kasper, Sterckx Sigrid, Schermer Maartje
Department of Medical Ethics and Philosophy, ErasmusMC University Medical Center Rotterdam, P,O, Box 2040, 3000, CA, Rotterdam, The Netherlands.
BMC Med Ethics. 2014 Sep 16;15:67. doi: 10.1186/1472-6939-15-67.
The debate on the ethical aspects of moral bioenhancement focuses on the desirability of using biomedical as opposed to traditional means to achieve moral betterment. The aim of this paper is to systematically review the ethical reasons presented in the literature for and against moral bioenhancement.
A review was performed and resulted in the inclusion of 85 articles. We classified the arguments used in those articles in the following six clusters: (1) why we (don't) need moral bioenhancement, (2) it will (not) be possible to reach consensus on what moral bioenhancement should involve, (3) the feasibility of moral bioenhancement and the status of current scientific research, (4) means and processes of arriving at moral improvement matter ethically, (5) arguments related to the freedom, identity and autonomy of the individual, and (6) arguments related to social/group effects and dynamics. We discuss each argument separately, and assess the debate as a whole. First, there is little discussion on what distinguishes moral bioenhancement from treatment of pathological deficiencies in morality. Furthermore, remarkably little attention has been paid so far to the safety, risks and side-effects of moral enhancement, including the risk of identity changes. Finally, many authors overestimate the scientific as well as the practical feasibility of the interventions they discuss, rendering the debate too speculative.
Based on our discussion of the arguments used in the debate on moral enhancement, and our assessment of this debate, we advocate a shift in focus. Instead of speculating about non-realistic hypothetical scenarios such as the genetic engineering of morality, or morally enhancing 'the whole of humanity', we call for a more focused debate on realistic options of biomedical treatment of moral pathologies and the concrete moral questions these treatments raise.
关于道德生物增强伦理层面的争论聚焦于使用生物医学手段而非传统手段来实现道德提升是否可取。本文旨在系统回顾文献中支持和反对道德生物增强的伦理理由。
进行了一项综述,共纳入85篇文章。我们将这些文章中使用的论点分为以下六类:(1)我们为何(不)需要道德生物增强,(2)就道德生物增强应包含的内容达成共识(不)可行,(3)道德生物增强的可行性及当前科学研究的状况,(4)实现道德提升的手段和过程在伦理上很重要,(5)与个人自由、身份和自主性相关的论点,以及(6)与社会/群体影响和动态相关的论点。我们分别讨论每个论点,并对整个争论进行评估。首先,关于道德生物增强与道德病理缺陷治疗之间的区别讨论甚少。此外,到目前为止,对于道德增强的安全性、风险和副作用,包括身份改变的风险,关注明显不足。最后,许多作者高估了他们所讨论干预措施的科学及实际可行性,使得这场争论过于思辨。
基于我们对道德增强争论中使用的论点的讨论以及对这场争论的评估,我们主张转变焦点。我们呼吁不要去推测诸如道德基因工程或对“全人类”进行道德增强等不切实际的假设情景,而是针对道德病理的生物医学治疗的现实选择以及这些治疗引发的具体道德问题展开更具针对性的辩论。